MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41588-018-0251-4

Медицинская библиотека · Nature genetics · 2018

Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.

Gayden Tenzin, Sepulveda Fernando E, Khuong-Quang Dong-Anh, Pratt Jonathan, Valera Elvis T, Garrigue Alexandrine, Kelso Susan, Sicheri Frank, Mikael Leonie G, Hamel Nancy, Bajic Andrea, Dali Rola, Deshmukh Shriya, Dervovic Dzana, Schramek Daniel, Guerin Frédéric, Taipale Mikko, Nikbakht Hamid, Majewski Jacek, Moshous Despina, Charlebois Janie, Abish Sharon, Bole-Feysot Christine, Nitschke Patrick, Bader-Meunier Brigitte, Mitchell David, Thieblemont Catherine, Battistella Maxime, Gravel Simon, Nguyen Van-Hung, Conyers Rachel, Diana Jean-Sebastien, McCormack Chris, Prince H Miles, Besnard Marianne, Blanche Stephane, Ekert Paul G, Fraitag Sylvie, Foulkes William D, Fischer Alain, Neven Bénédicte, Michonneau David, de Saint Basile Geneviève, Jabado Nada

Письмо в редакциюПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Subcutaneous panniculitis-like T cell lymphoma (SPTCL), a non-Hodgkin lymphoma, can be associated with hemophagocytic lymphohistiocytosis (HLH), a life-threatening immune activation that adversely affects survival1,2. T cell immunoglobulin mucin 3 (TIM-3) is a modulator of immune responses expressed on subgroups of T and innate immune cells. We identify in ~60% of SPTCL cases germline, loss-of-function, missense variants altering highly conserved residues of TIM-3, c.245A>G (p.Tyr82Cys) and c.291A>G (p.Ile97Met), each with specific geographic distribution. The variant encoding p.Tyr82Cys TIM-3 occurs on a potential founder chromosome in patients with East Asian and Polynesian ancestry, while p.Ile97Met TIM-3 occurs in patients with European ancestry. Both variants induce protein misfolding and abrogate TIM-3's plasma membrane expression, leading to persistent immune activation and increased production of inflammatory cytokines, including tumor necrosis factor-α and interleukin-1β, promoting HLH and SPTCL. Our findings highlight HLH-SPTCL as a new genetic entity and identify mutations causing TIM-3 alterations as a causative genetic defect in SPTCL. While HLH-SPTCL patients with mutant TIM-3 benefit from immunomodulation, therapeutic repression of the TIM-3 checkpoint may have adverse consequences.

Для цитирования: Gayden Tenzin, Sepulveda Fernando E, Khuong-Quang Dong-Anh, Pratt Jonathan, Valera Elvis T, Garrigue Alexandrine, Kelso Susan, Sicheri Frank, Mikael Leonie G, Hamel Nancy, Bajic Andrea, Dali Rola, Deshmukh Shriya, Dervovic Dzana, Schramek Daniel, Guerin Frédéric, Taipale Mikko, Nikbakht Hamid, Majewski Jacek, Moshous Despina, Charlebois Janie, Abish Sharon, Bole-Feysot Christine, Nitschke Patrick, Bader-Meunier Brigitte, Mitchell David, Thieblemont Catherine, Battistella Maxime, Gravel Simon, Nguyen Van-Hung, Conyers Rachel, Diana Jean-Sebastien, McCormack Chris, Prince H Miles, Besnard Marianne, Blanche Stephane, Ekert Paul G, Fraitag Sylvie, Foulkes William D, Fischer Alain, Neven Bénédicte, Michonneau David, de Saint Basile Geneviève, Jabado Nada. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.. Nature genetics. 2018. DOI: 10.1038/s41588-018-0251-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.